Patent · US Active

2-morpholino-pyrido[3,2-D]pyrimidines

US8609666B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2010
Grant dateDec 17, 2013
Priority date—
Expiry dateAug 1, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other diseases like cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.